Copy Number Variant Duplications Associated with Essential Tremor

Read full text
Authors: Miranda Medeiros, Calwing Liao, Allison Ann Dilliott, Jay P. Ross, Veikko Vuokila, Farah Aboasali, Charles-Etienne Castonguay, Dan Spiegelman, Franziska Hopfner, Carles Vilariño-Güell, Elena García-Martín, Hortensia Alonso-Navarro
+11 more José A. G. Agúndez, Félix Javier Jiménez‐Jiménez, Pau Pástor, Alex Rajput, Ali H. Rajput, Günther Deuschl, Gregor Kuhlenbäumer, Simon L. Girard, Sali M.K. Farhan, Patrick A. Dion, Guy A. Rouleau
Cited by: 1
References: 32

Abstract

Background: Essential tremor (ET) is a complex neurological disorder with a strong genetic basis, yet there remains a disparity between its estimated heritability and currently known genetic risk. This missing heritability has led to a lack of appropriate treatments and has exacerbated the misdiagnosis of patients. Methods: To address the missing heritability of ET, we called copy number variants (CNVs) in a large cohort of ET patients (n = 1,853) and unaffected controls (n = 10,336). CNVs were called from single nucleotide polymorphism (SNP) microarray data using PennCNV and QuantiSNP and only rare CNVs (frequency < 1%) intersecting protein coding regions of the genome were analyzed. To investigate whether CNV occurrence was associated with ET, global burden, pathogenicity burden, gene set enrichment, and gene burden tests were conducted. Results: Global duplication burden by CNV number, CNV length, and number of genes affected by CNVs were all significantly elevated in ET patients compared to controls. Across gene-sets, duplications affecting Mendeliome genes, genes highly expressed in the brain, and genes expressed in the cerebellum were significantly enriched in patients compared to controls. Gene-based burden testing indicated that duplications involving ZNF813 were significantly less frequent in ET patients than in controls. No associations with deletion events were observed. Discussion: Our results point to rare copy number duplications affecting protein coding regions of the genome as likely contributors to ET genetic risk. However, specific susceptibility genes could not be reliably identified, highlighting the need for larger studies of diverse variant types to clarify the genetic architecture of ET.

Fields of Study & Subjects

Neurological disorders and treatments Glycogen Storage Diseases and Myoclonus Genetics and Neurodevelopmental Disorders

Publication details

Journal / source
Tremor and Other Hyperkinetic Movements
Publisher
Ubiquity Press, Ltd.
Volume
16
Pages
10–10
Publication date
10 February 2026
Language
EN